Toggle navigation
Home
Search
Services
Blog
Contact
About
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M.
Valentis, Inc., Burlingame, CA, United States
Search grants from Eric Eastman
Search grants from Valentis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neuronal circuits for context-driven bias in auditory categorization
Paradoxical roles of Nrf2 activation in arsenic-induced beta-cell dysfunction
In Utero Stem Cell Transplantation
Vasopressin-Crf-Acth Interactions in the Conscious State
Long Range Electron Transfer in Rigid Ru(III) Systems
Recently added grants:
Boston HIV CTU
San Francisco Bay Clinical Trials Unit (CTU)
Elucidating SHIP1 in microglia in health and disease
Modulation of innate immune cells to create transplant tolerance
Schistosomiasis at the edge of elimination: characterizing sources of new infections in residual transmission hotspots
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NS033069-02
Application #
2037813
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Project Start
1994-06-10
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Valentis, Inc.
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Related projects
NIH 1997
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Nordstrom, Jeffrey L. / Valentis, Inc.
NIH 1996
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M. / Valentis, Inc.
Comments
Be the first to comment on Eric Eastman's grant